CCRB Logo

Trial History Detail on 2013-09-11

CUHK_CCT00153

2008-02-15

Prospective

Nil

Departmental funding from DOVS, CUHK (for the drug bevacizumab (avastin))

Nil

Nil

Dr. Yolanda YY Kwong

3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon.

27623000

email kwongyyy@yahoo.com

Hong Kong Eye Hospital

Prof. Dennis SC Lam

3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon.

27623134

email dennislam_cu_res@cuhk.edu.hk

Department of Opthalmology and Visual Sciences, The Chinese University of Hong Kong

Needling with adjunctive intravitreal injection of bevacizumab (avastin). A preliminary study.

Needling with adjunctive intravitreal injection of bevacizumab (avastin). A preliminary study.

Nil

Hong Kong

Yes

2007-08-29

Glaucoma

Other

Drug+Procedure

Needling with intravitreal injection of Bevacizumab (Avastin)

10-15 minutes

No control or comparative treatment for this study

Inclusion Criteria 1. Age 18 years or above 2. Eyes that undergo needling 3. Patient able and willing to give informed consent to needling with intra-vitreal injection of bevacizumab.

Exclusion criteria 1. Single functional eye 2. Pregnant patients 3. Patients refusing needling or bevacizumab injection 4. Use of anticoagulants or antiplatelet therapy other than aspirin/NSAIDs within 14 days of surgery. 5. Presence of a nonhealing wound, ulcer, fracture, or any medical condition associated with bleeding

18

None set

Both Male and Female

Interventional

Non-randomized

Uncontrolled

Open label

Single group

2008-02-21

30

Complete

Intraocular pressure

1. Bleb morphology (with photographic record) 2. Visual acuity 3. Number of IOP-lowering medications 4. Corneal clarity and corneal endothelial cell count (by specular microscopy) 5. Lens status 6. Progression in glaucomatous optic neuropathy and visual field loss 7. Any complications from surgery

No

2012-04-17

ChiCTR-TRC-08000711

2010-05-04


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.